Autres langues Kissei Pharmaceutical Co., Ltd.

Actions

4547

JP3240600001

Temps Différé Japan Exchange Autres places de cotation 03:37:52 13/05/2024			Varia. 5j.	Varia. 1 janv.
3 120 ^JPY	-2,04 %		-14,52 %	+0,97 %

08/05	Les actions japonaises virent au rouge dans un contexte de prises de bénéfices et d'incertitude quant à la baisse des taux d'intérêt américains	MT
04/01	Kissei Pharmaceutical rachète 251 millions de yens d'actions en décembre 2023	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Japanese Shares Swing to Red Amid Profit-Taking, US Rate Cut Uncertainty	08/05
Kissei Pharmaceutical's Attributable Profit Jumps 6% in Fiscal 2023; Shares Tumble 11%	08/05
Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program	20/03
Kissei Pharmaceutical : Notice Concerning Status of Acquisition and Completion of the Company's Own Shares	19/03
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	19/03
Kissei Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 8, 2023, has closed with 1,909,900 shares, representing 4.18% for ¥5,999.99 million.	18/03
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/03
Kissei Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 2024	30/01
Kissei Pharmaceutical Repurchases 251 Million Yen Worth of Shares in December 2023	04/01
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	04/01
Kissei and Maruishi Debut Injection for Dialysis-Related Itching	13/12
Kissei Pharmaceutical : KORSUVA® IV Injection Syringe for Dialysis 17.5μg, 25.0μg and 35.0μg to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12/12
Kissei Pharmaceutical Co., Ltd. and Maruishi Pharmaceutical Co., Ltd. Announces KORSUVA®? IV Injection Syringe for Dialysis 17.5ug, 25.0ug to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12/12
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/12
Kissei Pharmaceutical : Introduces Natural Language Processing System	17/11
Japanese Shares Close Lower on Tuesday After Key Economic Data	07/11
Kissei Pharmaceutical's Fiscal H1 Attributable Profit Surges as Net Sales Gains	07/11
Kissei Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	06/11
Kissei Pharmaceutical Co., Ltd. Announces Second Quarter-End Dividend for the Year Ending March 31, 2024, Payable on December 4, 2023 and Provided Dividend Guidance for the Year Ending March 31, 2024	06/11
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Kissei Pharmaceutical Co., Ltd.

Actions

4547

JP3240600001

Autres langues

Filtres